Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive traet

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

303

HTML

3204

Tables (1-9)

117

Sum=3624

Mar 15, 2003 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Mar 15, 2003; 9(3): 495-498
Published online Mar 15, 2003. doi: 10.3748/wjg.v9.i3.495

Table 5 Comparison of median survival period, mean survival period of resected colorectal cancer patients of vaccina-tion group and controlled group

Treatment method	n	Median survival period (year)	Mean survival period (year)
Resection plus vaccination group	310	> 7^a	5.13 ± 0.60^b
Resection alone group	257	4.46	4.15 ± 0.60

^bP < 0.01 vs resection alone group.

Citation: Liang W, Wang H, Sun TM, Yao WQ, Chen LL, Jin Y, Li CL, Meng FJ. Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive traet. World J Gastroenterol 2003; 9(3): 495-498
URL: https://www.wjgnet.com/1007-9327/full/v9/i3/495.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i3.495